research use only
Cat.No.S5726
|
In vitro |
DMSO
: 100 mg/mL
(153.61 mM)
0.1M NAOH : 1.56 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 650.97 | Formula | C15H12I3NO4 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 6893-02-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | 3,3',5-Triiodo-L-thyronine | Smiles | C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O | ||
| In vitro |
T3 (Triiodothyronine) is one ingredient supplemented in the medium for inducing brown adipocytes differentiation. |
References |
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06341517 | Not yet recruiting | Schizophrenia; Psychosis |
Indrit Begue|University of Geneva Switzerland |
November 5 2024 | Not Applicable |
| NCT05333432 | Not yet recruiting | Prostate Cancer |
Assistance Publique - Hôpitaux de Paris|National Cancer Institute France |
June 1 2024 | Not Applicable |
| NCT06323538 | Not yet recruiting | Dietary Exposure|Diabetes Mellitus Type 2|Cardiovascular Diseases|Bone Loss|Sustainability|Exposure|Obesity|Vitamin Deficiency|Mineral Deficiency |
German Federal Institute for Risk Assessment|Max Rubner-Institut|University of Bonn|Research Institute for Plant-Based Nutrition|University of Jena|University of Regensburg|Heidelberg University|University of Vienna |
April 1 2024 | -- |
| NCT06345924 | Recruiting | Cancer|Palliative Care |
University of Valencia |
March 1 2024 | Not Applicable |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.